63684-99-1 Usage
Uses
Used in Pharmaceutical Industry:
1-(3,4-DICHLOROPHENYL)-5-MERCAPTO-1H-TETRAZOLE is used as an intermediate in the synthesis of pharmaceuticals for its potential therapeutic effects on various diseases. It has been studied for its possible use in treating cancer and cardiovascular disorders due to its unique chemical structure and biological activity.
Used in Agrochemical Industry:
In the agrochemical sector, 1-(3,4-DICHLOROPHENYL)-5-MERCAPTO-1H-TETRAZOLE serves as an intermediate in the production of agrochemicals, contributing to the development of new compounds with pesticidal or herbicidal properties.
Used in Material Science:
1-(3,4-DICHLOROPHENYL)-5-MERCAPTO-1H-TETRAZOLE is utilized as a building block in material science for the creation of novel polymeric materials. Its incorporation into polymer structures can lead to the development of advanced materials with specific properties for various applications.
Overall, 1-(3,4-DICHLOROPHENYL)-5-MERCAPTO-1H-TETRAZOLE is a versatile chemical entity with significant implications in drug discovery, agrochemical development, and materials research, making it an important molecule for further exploration and application.
Check Digit Verification of cas no
The CAS Registry Mumber 63684-99-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,6,8 and 4 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 63684-99:
(7*6)+(6*3)+(5*6)+(4*8)+(3*4)+(2*9)+(1*9)=161
161 % 10 = 1
So 63684-99-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H4Cl2N4S/c8-5-2-1-4(3-6(5)9)13-7(14)10-11-12-13/h1-3H,(H,10,12,14)
63684-99-1Relevant academic research and scientific papers
Tetrazole thioacetanilides: Potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutant
Muraglia, Ester,Kinzel, Olaf D.,Laufer, Ralph,Miller, Michael D.,Moyer, Gregory,Munshi, Vandna,Orvieto, Federica,Palumbi, Maria Cecilia,Pescatore, Giovanna,Rowley, Michael,Williams, Peter D.,Summa, Vincenzo
, p. 2748 - 2752 (2007/10/03)
A series of aryltetrazolylacetanilides was synthesized and evaluated as HIV-1 non-nucleoside reverse transcriptase inhibitors on wild-type virus and on the clinically relevant K103N mutant strain. Extensive SAR investigation led to potent compounds, with nanomolar activity on K103N, and orally bioavailable in rats.
